Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5qEkaterina Balaian, Martin Wermke, Martin Bornhäuser et al.|Annals of Hematology|2016Cited by 12
Disease-modifying activity of ruxolitinib in a patient with <i>JAK2</i>-negative CMML-2Silvan Francke, Uwe Platzbecker, Anna Mies et al.|Leukemia & lymphoma/Leukemia and lymphoma|2016Cited by 5
Targeting the Inflammatory Niche in MDS By Tasquinimod Restores Hematopoietic Support and Suppresses Immune-Checkpoint Expression <i>in Vitro</i>Manja Wobus, Katja Sockel, Ekaterina Balaian et al.|Blood|2021Cited by 2
Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo‐Controlled Phase 2 <scp>DELTA</scp> TrialKatja Sockel, Uwe Platzbecker, Christoph Röllig et al.|American Journal of Hematology|2025Cited by 0